abstract |
The present invention discloses a compound represented by formula I, or its stereoisomer, or its pharmaceutically acceptable salt, or its solvate, or its prodrug, or its metabolite. Tests show that the compounds of the present invention have good ROCK inhibitory activity and can be effectively used for the treatment of diseases with abnormal ROCK activity. |